Reneuron Group Plc

Reneuron (RENE)

Company name:Reneuron Group Plc
EPIC:RENETrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BF5G6K95
Market Segment:ASQ1Share Type:DE
WWW Address:http://www.reneuron.com/Description:ORD 1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 238.00 uk.advfn.com/p.php?gfx=/gb/down -6.0 [-2.46] 235.00 245.00 244.00 244.00 240.00 62,362
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 75.69 31.80 -0.29 -45.20 - - - 332.50 - 47.00

Reneuron Key Figures

(at previous day's close)
Market Cap.75.69m
Shares In Issue31.80m
Prev. Close244.00
PE Ratio- 
Dividend Yield-%
EPS - basic-45.20p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-37.71p
Return On Equity (ROE)-61.03%
Operating Margin-35,059.18%
PEG Factor- 
EPS Growth Rate18.85%
Dividends PS Growth Rate-%
Net Debt-13.00m
Gross Gearing24.09%
Quick Assets24.08m
Net Working Capital16.65m
Intangibles / Fixed Assets2.75%
Turnover PS0.15p
Pre-Tax Profit PS-54.02p
Retained Profit PS-44.94p
Cash PS64.25p
Net Cash PS40.88p
Net Tangible Asset Value PS *73.05p
Net Asset Value PS73.63p
Spread10.00 (4.08%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Reneuron Balance Sheet

LSE:RENE:Liabilities+EQLSE:RENE:Assets

Share Price Performance

Sample Period †HighLow
1 week262.50230.00
4 weeks277.50187.50
12 weeks332.50187.50
1 year332.5047.00

Share Price Chart (5 years)

Reneuron Historic Returns

Period †OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week242.50-4.50-1.86230.000.09244.83
4 weeks207.5030.5014.70187.500.11238.81
12 weeks277.50-39.50-14.23187.500.19276.11
26 weeks51.50186.50362.1447.500.31170.57
1 year93.50144.50154.5547.000.16163.01
3 years300.00-62.00-20.671.451.52211.63
5 years368.00-130.00-35.331.452.08312.22
† periods calculated are whole weeks rather than calendar months

Reneuron Key Management Ratios

Reneuron Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 2.06 
Tobin's Q Ratio (excl. intangibles)2.07 
Dividend Yield-%
Market-to-Book Ratio3.23 
Price-to-Pre-Tax Profit PS-4.41 
Price-to-Retained Profit PS-5.30 
Price-to-Cash Flow PS-6.31 
Price-to-Sales PS1,544.65 
Price-to-Net Tangible Asset Value PS3.26 
Price-to-Cash PS3.70 
Net Working Capital PS52.34 
Price Pct to Working Capital PS4.55%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Reneuron Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-42.15%
Net Gearing (excl. Intangibles)-42.41%
Gross Gearing24.09%
Gross Gearing (excl. Intangibles)24.23%
Gearing Under 1 Year24.09%
Gearing Under 1 Year (excl. Intgbl)24.23%
Assets/Equity1.32 
Cash/Equity87.25 
(Liquidity Ratios)
Net Working Capital to Total Assets53.96%
Current Ratio3.24 
Quick Ratio (Acid Test)3.24 
Liquidity Ratio2.75 
Cash & Equiv/Current Assets84.87%
(Solvency Ratios)
Enterprise Value55.26m
CFO/Sales-244.73 
CFO/Attributable Profit- 
CFO/Assets-0.39 
CFO/Debt-1.61 
Total Debt/Equity Market Value0.10 
Total Debt/Sales151.63 
Total Debt/Pre-Tax Profit-0.43 
Total Debt7.43m
Total Debt/Net Current Assets0.45%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-2.79%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs2 
Beta (60-Mnth)Beta (36-Mnth)
-0.2925-0.1325

Reneuron Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-73.36%
Return On Assets (ROA)-38.91%
Net Profit Margin-29,167.35%
Assets Turnover0.00 
Return On Equity (ROE)-61.03%
Return On Investment (ROI)-47.57%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-29,167.35%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.00 
Fixed Assets Turnover0.01 
Current Assets Turnover0.00 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales749.64 
Debtors-to-Sales8,100.00%
Debt Collection Period29,565.00Days

Reneuron Dividends

Sorry No Data Available

Reneuron Fundamentals
 31 Mar 2016 (GBP)31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)
turnover0.03-0.05-0.04-0.05-m
pre tax profit-12.85--18.17--20.97--17.18-m
attributable profit-11.35--15.57--17.62--14.29-m
retained profit-11.35--15.57--17.62--14.29-m
eps - basic (p)-0.40 -49.20 -55.70 -45.20 
eps - diluted (p)-0.40 -49.20 -55.70 -45.20 
dividends per share- - - - 

Reneuron Balance Sheet

 31 Mar 2016 (GBP)31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)
LSE:RENE:Liabilities+EQLSE:RENE:AssetsLSE:RENE:Liabilities+EQLSE:RENE:AssetsLSE:RENE:Liabilities+EQLSE:RENE:AssetsLSE:RENE:Liabilities+EQLSE:RENE:Assets
 31 Mar 2016 (GBP)31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)
ASSETS
fixed assets fixed assets0.360.50%0.721.23%0.731.70%0.632.05%m
intangibles intangibles1.592.21%--%0.190.44%0.190.60%m
fixed investments fixed investments48.2867.19%24.9442.36%9.5022.29%5.9519.30%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors4.205.84%5.088.62%4.3010.08%3.6411.81%m
cash & securities cash & securities17.4324.25%28.1347.78%27.9165.49%20.4366.24%m
TOTAL71.86100%58.86100%42.62100%30.85100%m
LIABILITIES
creditors - short creditors - short4.205.84%5.709.69%5.9513.96%7.4324.09%m
creditors - long creditors - long--%0.000.00%--%--%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL4.205.84%5.709.69%5.9513.96%7.4324.09%m
EQUITY
ord cap, reserves ord cap, reserves67.6694.16%53.1690.31%36.6786.04%23.4275.91%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL67.6694.16%53.1690.31%36.6786.04%23.4275.91%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Reneuron Cash Flow Statement

31 Mar 2016 (GBP)31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)
Operating CF-11.92-12.64-14.89-11.99m
Pre-Financing CF-11.87-12.65-14.74-11.84m
Retained CF5.0410.70-0.21-7.48m

Reneuron Brokers

NameActivityTypeMnemonicCode
Collins Stewart Europe LimitedMarket Maker(MMF)Broker/DealerCSCSCSTEGB21
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Liberum Capital LimitedMarket Maker(MMF)Broker/DealerLIBCLCAPGB21
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
RENE
Reneuron
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190721 10:54:01